Welcome

CDC Advisers to Meet Nov. 19 on Wider Pfizer Booster Access (1)

Nov. 16, 2021, 10:47 PM

The panel that advises the Centers for Disease Control and Prevention on vaccination policies has scheduled a meeting for Nov. 19 to discuss expanding eligibility for booster shots of the vaccine produced by Pfizer Inc. and BioNTech SE.

Pfizer asked federal regulators to sign off on an expansion of booster-shot eligibility earlier this month. The third shots are currently authorized for people 65 and older, as well as people 18 and up at higher risk of severe Covid. The CDC confirmed the advisory committee’s agenda in an email.

The Biden administration has been eager to get more supplemental doses into ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.